Cited by 111RNA Interference and Gene DeliveryNanoparticle-Based Drug DeliveryInhalation and Respiratory Drug Delivery

Systemic mRNA delivery to the lungs by functional polyester-based carriers

Yan, Yunfeng, Xiong, Hu, Zhang, Xinyi, Cheng, Qiang, Siegwart, Daniel J.·2017·Biomacromolecules

Abstract

Messenger RNA (mRNA) has recently come into focus as an emerging therapeutic class with great potential for protein replacement therapy, cancer immunotherapy, regenerative medicine, vaccines, and gene editing. However, the lack of effective and safe delivery methods impedes the broad application of mRNA-based therapeutics. We report a robust approach to develop efficient polymeric delivery carriers for mRNA. Lead polyesters were identified by in vitro screening of a 480-member combinatorially modified poly(trimethylolpropane allyl ether-co-suberoyl chloride) library for the delivery of luciferase encoding mRNA (Luc mRNA) to IGROV1 cells. The formulation of mRNA polyplex nanoparticles (NPs) with Pluronic F127 decreased the surface charge. Although this improved the stability of mRNA nanoparticles, the delivery potency decreased with increased F127 content. Thus, we determined that NP stabilization with 5% F127 could balance the protective effects and delivery potency. 5% F127 formulated PE4K-A17-0.33C12 mRNA NPs enabled luciferase expression predominantly in the lungs after intravenous injection into mice. The efficient mRNA delivery specifically to lungs by degradable carriers suggests the potential for the treatment of pulmonary diseases.

Integrity signals

Registry

Crossref · 10.1021/acs.biomac.7b01356

Cites

64 of 64 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • PE4K-A17-0.33C12 nanoparticles formulated with 5% pluronic F127 resulted in obvious luciferase expression in the lungs after systemic administration in mice.

    “The PE4K-A17–0.33C12 nanoparticles formulated with 5% pluronic F127 resulted in obvious luciferase expression in the lungs after systematic administration in mice.[195]”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Yan, Y., Xiong, H., Zhang, X., Cheng, Q., & Siegwart, D. J.
Affiliations
Harold C. Simmons Comprehensive Cancer Center (US)
Corresponding author
  • Yan, Yunfeng
  • Siegwart, Daniel J.
Venue
Biomacromolecules
Published
2017-11-27
Volume
18
Issue
12
Pages
4307-4315
ISSN
  • 1525-7797 (ISSN-L)
  • 1526-4602
OpenAlex
W2770318482
Cited by
111
References
64
Citations by year
2026: 4 · 2025: 14 · 2024: 19 · 2023: 18 · 2022: 12 · 2021: 13 · 2020: 10 · 2019: 6 · 2018: 15
FWCI
3.46
Type
journal article
Language
en
Open access
closed
Locations
  • Biomacromolecules (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Welch Foundation (I-1855)
  • Cancer Prevention and Research Institute of Texas (R1212)
  • American Cancer Society (RSG-17-012-01)
  • Mary Kay Foundation (049-15)
  • Zhejiang University of Technology (105008529)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Inhalation and Respiratory Drug Delivery
Keywords
mRNA delivery, pulmonary drug delivery, polyester nanoparticles, Pluronic F127, polymeric carriers, luciferase expression, intravenous injection, lung disease, surface charge, nanoparticle stability
MeSH terms
Animals, Drug Carriers, Humans, Lung, Polyesters, Polymers, RNA, Messenger, Mice, SCID, Mice, Inbred NOD, Poloxamer, Cell Line, Tumor, Mice, Nanoparticles

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review